Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
IDT AustraliaASX:IDT EV-to-EBITDA is -5.61 as of Jul. 25, 2026. The stock has 6 warning signs investors should review. Among 742 Drug Manufacturers companies, IDT Australia ranks worse than 134770.75% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, IDT Australia's enterprise value is A$20.37 Mil.
IDT Australia's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was A$-3.63 Mil. Therefore, IDT Australia's EV-to-EBITDA for today is -5.61.
The historical rank and industry rank for IDT Australia's EV-to-EBITDA or its related term are showing as below:
ASX:IDT'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -85.74 Med: -3.01 Max: 128.62
Current: -5.61
During the past 13 years, the highest EV-to-EBITDA of IDT Australia was 128.62. The lowest was -85.74. And the median was -3.01.
ASX:IDT's EV-to-EBITDA is ranked worse than 100% of 742
companies
in the Drug Manufacturers industry
Industry Median: 12.96
vs ASX:IDT: -5.61
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).
IDT Australia (ASX:IDT) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
IDT Australia's PE Ratio (TTM) for today is calculated as:
IDT Australia's share price for today is A$0.034.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. IDT Australia's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was A$-0.014.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for IDT Australia's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, IDT Australia's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
IDT Australia EV-to-EBITDA vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, IDT Australia's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where IDT Australia's EV-to-EBITDA falls into.
IDT Australia's current Enterprise Value is A$20.37 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. IDT Australia's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was A$-3.63 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
IDT Australia (ASX:IDT) has a EV-to-EBITDA of -5.61 as of Jul. 25, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on IDT Australia. According to the industry distribution chart, IDT Australia ranks #999999 out of 742 companies in the Drug Manufacturers industry.
Is IDT Australia's EV-to-EBITDA too high?
IDT Australia's current EV-to-EBITDA is -5.61. Based on the distribution chart, IDT Australia ranks #999999 out of 742 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers.
How does IDT Australia's EV-to-EBITDA compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, IDT Australia ranks #999999 out of 742 companies for EV-to-EBITDA. This places IDT Australia in the lower half of its industry. The industry median EV-to-EBITDA is 12.96. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Drug Manufacturers company?
The median EV-to-EBITDA among Drug Manufacturers companies is 12.96, based on 742 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on IDT Australia. For the Drug Manufacturers industry, the median EV-to-EBITDA is 12.96 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. IDT Australia's current EV-to-EBITDA is -5.61. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IDT Australia stock overvalued right now?
Based on GuruFocus' analysis, IDT Australia (ASX:IDT) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.17, compared to a current price of A$0.03 — trading 80% below its estimated fair value. The current EV-to-EBITDA is -5.61. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For IDT Australia (ASX:IDT), the current EV-to-EBITDA is -5.61 as of Jul. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
IDT Australia Ltd produces, develops, and supplies pharmaceutical products. It is engaged in the provision of research and development and other technical services for the pharmaceutical and allied industries. The company is involved in the manufacture of Active Pharmaceutical Ingredients (API) and Finished Dose Forms (FDF), microbiological and analytical testing, clinical packaging, and pharmacy services. The company operates in Australia, Asia, Europe, and the USA.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:IDT has been successfully added to your 
